# Source: Huntsman Cancer Institute Official Pages (Leadership, NCI Designation, U2TAH)

**Type:** source
**Status:** Useful
**Confidence:** Medium
**Source Type:** Official Website
**URL:** https://healthcare.utah.edu/huntsmancancerinstitute
**Publisher:** Huntsman Cancer Institute / University of Utah Health
**Accessed:** 2026-06-18
**Updated:** 2026-06-18

## Summary

Official University of Utah Health and NCI pages about Huntsman Cancer Institute, including the September 2025 press release announcing Bradley Cairns as CEO, the NCI Office of Cancer Centers profile, the 2025 Vineyard groundbreaking announcement, and University of Utah pages describing the U2TAH therapeutics accelerator.

## Useful Claims

- HCI is the NCI-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming, and describes itself as serving the largest land-area catchment of any US cancer center.
- HCI was founded by Jon M. and Karen Huntsman; it reports more than 400 open clinical trials and more than 300 research teams.
- HCI states that more genes for inherited cancers have been discovered there than at any other cancer center; the Utah Population Database underpins much of that work.
- Bradley Cairns, PhD, a chromatin/epigenetics biologist and longtime University of Utah researcher, became CEO on September 1, 2025, succeeding Mary Beckerle.
- The University of Utah Therapeutic Accelerator Hub (U2TAH) is a partnership of HCI, the College of Pharmacy, and the PIVOT Center, publicly described as established in October 2020 with a $22.5M commitment and led by senior managing director David Bearss; all disease areas are eligible.
- HCI and University of Utah Health broke ground in 2025 on a new Comprehensive Cancer Center in Vineyard, Utah.

## Reliability Notes

University and NCI pages are strong primary/institutional sources for designation, leadership, and program descriptions. Press releases are reliable for what the institution publicly commits to but are promotional in tone. The U2TAH founding date and current scope appear in different framings across sources (founding ~2020 versus later expansion); verify before strong claims. Patient volumes and funding totals are not pinned to primary figures here.

## Related Pages

- [Huntsman Cancer Institute](huntsman-cancer-institute.md)
- [Halia Therapeutics](halia-therapeutics.md)